Bausch Health Companies Stock Today
| BHC Stock | USD 7.47 0.13 1.71% |
Performance0 of 100
| Odds Of DistressLess than 34
|
Bausch Health is trading at 7.47 as of the 29th of January 2025, a 1.71 percent decrease since the beginning of the trading day. The stock's open price was 7.6. Bausch Health has about a 34 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 1st of October 2024 and ending today, the 29th of January 2025. Click here to learn more.
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company has 367.8 M outstanding shares of which 8.25 M shares are currently shorted by investors with about 6.24 days to cover. More on Bausch Health Companies
Moving against Bausch Stock
| 0.41 | MLAB | Mesa Laboratories Earnings Call This Week | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bausch Stock Highlights
| Chairman | William Humphries |
| Old Name | Bien Hoa Concrete JSC |
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, ARCA Pharmaceutical, SP TSX Composite, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
| Financial Strength | |
Bausch Health Companies (BHC) is traded on New York Stock Exchange in USA. It is located in 2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8 and employs 20,270 people. Bausch Health is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a total capitalization of 2.8 B. Bausch Health Companies runs under Pharmaceuticals sector within Health Care industry. The entity has 367.8 M outstanding shares of which 8.25 M shares are currently shorted by investors with about 6.24 days to cover.
Bausch Health Companies has about 564 M in cash with 1.03 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.34.
Check Bausch Health Probability Of Bankruptcy
Ownership AllocationBausch Health holds a total of 367.8 Million outstanding shares. The majority of Bausch Health Companies outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Bausch Health Companies to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Bausch Health. Please pay attention to any change in the institutional holdings of Bausch Health Companies as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bausch Ownership Details
Bausch Health Companies Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Bausch Health market risk premium is the additional return an investor will receive from holding Bausch Health long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.56) | |||
| Treynor Ratio | (1.19) |
Bausch Stock Against Markets
Bausch Health Corporate Directors
| Sarah Kavanagh | Independent Director | Profile | |
| Richard Schutter | Independent Director | Profile | |
| Amy Wechsler | Independent Director | Profile | |
| Robert Power | Independent Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.